Neurotoxic side-effects of cisplatin

Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies

1984 • 401 citations

Peripheral sensory neuropathy and cisplatin chemotherapy

1984 • 368 citations

Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian Cancer

1990 • 287 citations

ACTH accelerates recovery of neuromuscular function following crushing of peripheral nerve

1980 • 159 citations

High-dose cisplatin with sodium thiosulfate protection.

1985 • 148 citations

The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line

1990 • 123 citations

Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatin

1990 • 122 citations

Phase I/II trials of WR-2721 and cis-platinum

1986 • 114 citations

Effects of corticotrophin (ACTH) on recovery of sensorimotor function in the rat: Structure-activity study

1981 • 113 citations

Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ cell cancer.

1989 • 111 citations

Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer

1990 • 83 citations

Progressive paresthesias after cessation of therapy with very high-dose cisplatin

1989 • 81 citations

Efficacy of the neuropeptide ORG.2766 in the prevention and treatment of cisplatin-induced neurotoxicity in rats

1988 • 79 citations

Evaluation of cis-diamminedichloroplatinum (II) (cisplatin) neurotoxicity in rats

1987 • 69 citations

Vibration perception and thermoperception as quantitative measurements in the monitoring of cisplatin induced neurotoxicity

1989 • 57 citations

Clinical trials of WR-2721 and cis-platinum

1989 • 57 citations

A Preliminary Clinical Experience with Reduced Glutathione as Protector against Cisplatin-Toxicity

1987 • 47 citations

High-Dose Carboplatin With Diethyldithiocarbamate Chemoprotection in Treatment of Women With Relapsed Ovarian Cancer

1988 • 40 citations

Quantitative Sensory Testing Demonstrates That Subclinical Sensory Neuropathy Is Prevalent in Patients With Cancer

1987 • 35 citations

Cellular distribution of cis-diamminedichloroplatinum(II)-DNA binding in rat dorsal root spinal ganglia: Effect of the neuroprotecting peptide ORG.2766

1989 • 34 citations

Evolution of high-dose cisplatin

1988 • 32 citations

Cerebral herniation in patients receiving cisplatin

1988 • 32 citations

Spinal Cord Toxicity Complicating Treatment with Cisplatin and Etoposide

1990 • 26 citations

Action of hydrolyzed cisplatin and some analogs on microtubule protein polymerization in vitro.

1983 • 25 citations

High-dose cisplatin combination chemotherapy in the treatment of advanced epithelial ovarian carcinoma.

1990 • 24 citations

Prevention of cyclophosphamide-induced urotoxicity by reduced glutathione and its effect on acute toxicity and antitumor activity of the alkylating agent

1985 • 15 citations

Complete remission of paraneoplastic sensorimotor neuropathy: A case associated with small‐cell lung cancer responsive to chemotherapy, plasma exchange, and radiotherapy

1989 • 14 citations

Phase I and II Agents in Cancer Therapy: Two Cisplatin Analogues and High-Dose Cisplatin in Hypertonic Saline or With Thiosulfate Protection

1987 • 11 citations

Low prevalence of cisplatin-induced neuropathy after 4-day continuous infusion in head and neck cancer

1990 • 9 citations

The calcium antagonist nimodipine in cisplatin-induced neuropathy in the rat

1990 • 8 citations